AKU Global Patient Registry If you have been diagnosed with AKU anywhere in the world, you can make an important contribution to our research into understanding, treating, and curing the condition. Join the registry What is the AKU patient registry? Our global...
Funding opportunities We are constantly looking to fund research into developing new treatments and potential cures for AKU. The majority of our research is conducted in partnership with the University of Liverpool as well as a number of international partners. Below...
Other Research Gene therapy In partnership with the University of Liverpool, we have just begun a PhD programme looking at developing a gene therapy cure for AKU. We hope that the preliminary research conducted will create a foundation to explore the possibility of...
Hypertyrosinaemia We are currently conducting research into treating nitisinone-induced hypertyrosinaemia¹ in partnership with a number of collaborators including the University of Liverpool. Nitisinone is an extremely effective treatment which reduces homogentisic...
Diagnosis The diagnosis of AKU is made upon the identification of characteristic symptoms, patient history, and clinical evaluation. Identification of elevated levels of homogentisic acid (HGA) in the urine is indicative of AKU. AKU should be suspected of all...
